Terms: = Bone cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
78 results:
1. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant expression of gata3 in metastatic adenocarcinoma of the prostate: an important pitfall.
Lobo J; Tenace NP; Cañete-Portillo S; Carneiro I; Henrique R; Lucianò R; Harik LR; Magi-Galluzzi C
Histopathology; 2024 Feb; 84(3):507-514. PubMed ID: 37965687
[TBL] [Abstract] [Full Text] [Related]
3. Balance of gata3 and Ramp2 in hepatocytes regulates hepatic vascular reconstitution in postoperative liver regeneration.
Wang B; Shen H; Wei Y; Liu F; Yang Y; Yu H; Fu J; Cui X; Yu T; Xu Y; Liu Y; Dong H; Shen F; Zhou W; Liu H; Chen Y; Wang H
J Hepatol; 2024 Feb; 80(2):309-321. PubMed ID: 37918568
[TBL] [Abstract] [Full Text] [Related]
4. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen.
Schmutz M; Zucknick M; Schlenk RF; Mertens D; Benner A; Weichenhan D; Mücke O; Döhner K; Plass C; Bullinger L; Claus R
Clin Epigenetics; 2023 Oct; 15(1):171. PubMed ID: 37885041
[TBL] [Abstract] [Full Text] [Related]
5. Multiparametric imaging guided hdr interventional radiotherapy (brachytherapy) boost in localized prostate cancer: a multidisciplinary experience.
Tagliaferri L; Alemanno G; Fionda B; Alitto AR; Frascino V; Cellini F; Lancellotta V; Placidi E; Morganti AG; Kovács G; Giordano A; Manfredi R; Valentini V
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4175-4184. PubMed ID: 37203844
[TBL] [Abstract] [Full Text] [Related]
6. High dose rate brachytherapy in nonmelanoma skin cancer-Systematic review.
Krzysztofiak T; Kamińska-Winciorek G; Pilśniak A; Wojcieszek P
Dermatol Ther; 2022 Sep; 35(9):e15675. PubMed ID: 35770511
[TBL] [Abstract] [Full Text] [Related]
7. Safety and efficacy of salvage high-dose rate brachytherapy for prostate-bed recurrences following radical prostatectomy and external beam radiotherapy.
Aghili M; Jafari F; Yamrali M; Jaberi R; Cuccia F
Int Urol Nephrol; 2022 May; 54(5):1031-1037. PubMed ID: 35239137
[TBL] [Abstract] [Full Text] [Related]
8. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative hdr brachytherapy.
Gómez-Álvarez J; Martín Pastor S; Gimeno M; Lamo-Espinosa J; Ramos LI; Cambeiro M; Tagliaferri L; Kovacs G; Strnad V; San-Julián M; Martinez-Monge R
Radiother Oncol; 2022 May; 170():159-164. PubMed ID: 35227732
[TBL] [Abstract] [Full Text] [Related]
9. High-Dose Rate Interstitial Spine Brachytherapy Using an Intraoperative Mobile Computed Tomography-Guided Surgical Navigation System.
Medina R; Macyszyn L; Lim AS; Attiah M; Kafka-Peterson K; Kaprelian T; Hegde JV; Venkat P; Lee A; Park SJ; Chang AJ
Oper Neurosurg (Hagerstown); 2021 Nov; 21(6):507-515. PubMed ID: 34670276
[TBL] [Abstract] [Full Text] [Related]
10. Multidisciplinary approach to nose vestibule malignancies: setting new standards.
Bussu F; Tagliaferri L; Piras A; Rizzo D; Tsatsaris N; De Corso E; Parrilla C; Paludetti G
Acta Otorhinolaryngol Ital; 2021 Apr; 41(Suppl. 1):S158-S165. PubMed ID: 34060531
[TBL] [Abstract] [Full Text] [Related]
11. Validation of the collapsed cone algorithm for hdr liver brachytherapy against Monte Carlo simulations.
Duque AS; van Wagenberg T; Seidensticker M; Streitparth F; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Paiva Fonseca G; Corradini S; Landry G
Brachytherapy; 2021; 20(4):936-947. PubMed ID: 34001415
[TBL] [Abstract] [Full Text] [Related]
12. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract] [Full Text] [Related]
13. Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
Herreros-Pomares A; Llorens C; Soriano B; Bagan L; Moreno A; Calabuig-Fariñas S; Jantus-Lewintre E; Bagan J
Oral Oncol; 2021 May; 116():105191. PubMed ID: 33657465
[TBL] [Abstract] [Full Text] [Related]
14. A Case of Unknown Primary cancer with a Tumor Formed in the Retroperitoneum: A Case Report.
Tsuda B; Hirabayashi K; Sakaeda S; Ishida R; Mizuno M; Yokoyama K; Terao M; Morioka T; Okamura T; Watanabe T; Niikura N
Tokai J Exp Clin Med; 2020 Jul; 45(2):69-74. PubMed ID: 32602104
[TBL] [Abstract] [Full Text] [Related]
15. Gastric and adrenal metastasis from breast cancer: Case report and review of literature.
Tang T; Zhang L; Li C; Zhou T
Medicine (Baltimore); 2020 Jan; 99(3):e18812. PubMed ID: 32011488
[TBL] [Abstract] [Full Text] [Related]
16. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
[TBL] [Abstract] [Full Text] [Related]
17. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
Gu L; Zhang G; Zhang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
[TBL] [Abstract] [Full Text] [Related]
18. Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51.
Kaplan AR; Gueble SE; Liu Y; Oeck S; Kim H; Yun Z; Glazer PM
Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092693
[TBL] [Abstract] [Full Text] [Related]
19. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
[TBL] [Abstract] [Full Text] [Related]
20. c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and hdr Modulator Rad51 Expression.
Aksoz M; Albayrak E; Aslan GS; Turan RD; Alyazici LY; Siyah P; Tuysuz EC; Canikyan S; Yucel D; Meric N; Gulbas Z; Sahin F; Kocabas F
Curr Cancer Drug Targets; 2019; 19(6):479-494. PubMed ID: 30182856
[TBL] [Abstract] [Full Text] [Related]
[Next]
